Neurogenic hypertension.

作者信息

Paton Julian F R, Raizada Mohan K

出版信息

Exp Physiol. 2010 May;95(5):569-71. doi: 10.1113/expphysiol.2009.047282.

DOI:10.1113/expphysiol.2009.047282

PMID:20407134

Abstract

摘要

相似文献

Neurogenic hypertension.

Exp Physiol. 2010 May;95(5):569-71. doi: 10.1113/expphysiol.2009.047282.

Do changes in the coupling between respiratory and sympathetic activities contribute to neurogenic hypertension?

Clin Exp Pharmacol Physiol. 2009 Dec;36(12):1188-96. doi: 10.1111/j.1440-1681.2009.05202.x. Epub 2009 Apr 27.

The sixth Stevenson Lecture. The contribution of the sympathetic nervous system to arterial hypertension.

Can J Physiol Pharmacol. 1978 Jun;56(3):341-53. doi: 10.1139/y78-053.

[Neurogenic hypertension].

Ryoikibetsu Shokogun Shirizu. 1996(12):87-90.

Sympathetic abnormalities in human hypertension.

Clin Exp Hypertens (1978). 1981;3(3):417-38. doi: 10.3109/10641968109033674.

Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. The kidney is not always the target in neurogenic hypertension.

J Appl Physiol (1985). 2010 Dec;109(6):2008. doi: 10.1152/japplphysiol.01160.2010.

The sympathetic nervous system in hypertension: a potential long-term regulator of arterial pressure.

J Hypertens Suppl. 1996 Dec;14(5):S159-65.

Essential hypertension and the sympathetic nervous system.

Neurol Sci. 2008 May;29 Suppl 1:S33-6. doi: 10.1007/s10072-008-0882-9.

Neuropeptide Y and sympathetic control of vascular tone in hypertension.

EXS. 2006(95):89-103. doi: 10.1007/3-7643-7417-9_6.

Left ventricular hypertrophy and sympathetic activity.

Adv Exp Med Biol. 1997;432:173-9. doi: 10.1007/978-1-4615-5385-4_18.

引用本文的文献

Nasal turbinate lymphatic obstruction: a proposed new paradigm in the etiology of essential hypertension.

Front Med (Lausanne). 2024 Aug 16;11:1380632. doi: 10.3389/fmed.2024.1380632. eCollection 2024.

The feasibility, efficacy, and safety of RDN procedure using CO angiography through radial artery in severe chronic kidney disease patients.

Hypertens Res. 2024 Mar;47(3):760-766. doi: 10.1038/s41440-023-01540-3. Epub 2024 Jan 5.

Role of Inflammatory Processes in the Brain-Body Relationship Underlying Hypertension.

Curr Hypertens Rep. 2023 Dec;25(12):455-461. doi: 10.1007/s11906-023-01268-y. Epub 2023 Oct 3.

Neurogenic Hypertension, the Blood-Brain Barrier, and the Potential Role of Targeted Nanotherapeutics.

Int J Mol Sci. 2023 Jan 22;24(3):2213. doi: 10.3390/ijms24032213.

Central Administration of Hydrogen Sulfide Donor NaHS Reduces Iba1-Positive Cells in the PVN and Attenuates Rodent Angiotensin II Hypertension.

Front Neurosci. 2021 Sep 13;15:690919. doi: 10.3389/fnins.2021.690919. eCollection 2021.

Increased (Pro)renin Receptor Expression in the Hypertensive Human Brain.

Front Physiol. 2020 Nov 19;11:606811. doi: 10.3389/fphys.2020.606811. eCollection 2020.

Sympathetic Activation in Hypertensive Chronic Kidney Disease - A Stimulus for Cardiac Arrhythmias and Sudden Cardiac Death?

Front Physiol. 2020 Jan 14;10:1546. doi: 10.3389/fphys.2019.01546. eCollection 2019.

Increased (pro)renin receptor expression in the subfornical organ of hypertensive humans.

Am J Physiol Heart Circ Physiol. 2018 Apr 1;314(4):H796-H804. doi: 10.1152/ajpheart.00616.2017. Epub 2017 Dec 22.

Brain Transforming Growth Factor-β Resists Hypertension Via Regulating Microglial Activation.

Stroke. 2017 Sep;48(9):2557-2564. doi: 10.1161/STROKEAHA.117.017370. Epub 2017 Jul 11.

Effectiveness of renal sympathetic denervation in renal function and blood pressure in CKD and non-CKD patients with controlled uncontrolled hypertension.

Int J Cardiol Heart Vasc. 2016 Sep 7;13:3-5. doi: 10.1016/j.ijcha.2016.09.001. eCollection 2016 Dec.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验